EE363 Long Term Costs Assessment of Oral Therapies for Patients With Relapsing Multiple Sclerosis Based on the Evidence From a Large Real-World Study – Application to a Portuguese National Academic Hospital Center
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.609
https://www.valueinhealthjournal.com/article/S1098-3015(22)02813-3/fulltext
Title :
EE363 Long Term Costs Assessment of Oral Therapies for Patients With Relapsing Multiple Sclerosis Based on the Evidence From a Large Real-World Study – Application to a Portuguese National Academic Hospital Center
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02813-3&doi=10.1016/j.jval.2022.09.609
First page :
Section Title :
Open access? :
No
Section Order :
10140